STRS Ohio’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-85,800
Closed -$592K 2039
2017
Q1
$592K Buy
85,800
+20,600
+32% +$161K ﹤0.01% 1267
2016
Q4
$609K Buy
65,200
+4,680
+8% +$42.1K ﹤0.01% 1261
2016
Q3
$591K Buy
60,520
+18,220
+43% +$246K ﹤0.01% 1220
2016
Q2
$597K Buy
42,300
+1,500
+4% +$23.4K ﹤0.01% 1206
2016
Q1
$570K Buy
+40,800
New +$599K ﹤0.01% 1196
2014
Q4
Sell
-1,700
Closed -$32K 1836
2014
Q3
$32K Buy
+1,700
New +$30.8K ﹤0.01% 1701

Other funds holding AGTC

STRS Ohio's AGTC Position: Q2 2017 in Review

STRS Ohio sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 85,800 shares — an estimated $592K sold.

STRS Ohio first reported a position in AGTC in Q3 2014 and held it in 6 quarters. The position peaked at $609K in Q4 2016. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

  • STRS Ohio reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
  • STRS Ohio sold 85,800 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $592K.
  • STRS Ohio first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 6 quarters.
  • STRS Ohio's Applied Genetic Technologies Corporation position peaked at $609K in Q4 2016.
  • 77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on STRS Ohio's 13F filing for Q2 2017, filed 26 Jul 2017.